Background
This study evaluated the use of a CO2 laser for performing deep sclerectomy in nonpenetrating filtration surgery.
Methods
Three experimental models were performed: enucleated sheep and cow eyes (n=18) to determine optimal irradiation parameters, live rabbit eyes (n=20) to test feasibility, and cadaver eyes (40 procedures in 20 eyes) to study effects in human eyes tissue. After a half-thickness
scleral flap was created, deep sclerectomy was performed by CO2 laser applications on the scleral bed down to the trabeculo-Descemet’s membrane.
Results
Fluid percolation was repeatedly achieved without penetration in sheep and cow eyes using scanned laser energy of 5–10 W at
a pulse duration of 200 μs and a working distance of 35 cm. In live rabbits, deep sclerectomy was achieved without perforation
in 19/20 eyes. Intraocular pressure was significantly decreased on the first postoperative day (10.3±5.1 mmHg lower, on average,
than in the nonoperated fellow eye; P<0.001), and this persisted for 21 days. Operations on all cadaver eyes resulted in effective fluid percolation. Penetration
of the scleral wall occurred in five cases only after repeated laser applications with high energy. Histologically, a thin
sclerocorneal intact wall was demonstrated at the sclerectomy bed. Collateral tissue damage did not extend beyond 100 μm,
and adjacent structures remained unharmed.
Conclusions
CO2 laser-assisted deep sclerectomy is a feasible and apparently safe procedure.
Keywords Trabeculectomy - Sclerectomy - Penetrating filter surgery
Optomedic Ltd, Or-Yehuda, Israel, which does no longer exists, sponsored this study. Drs. Assia, Barequet and Belkin were
paid consultants of Optomedic Ltd. Currently, the IP of the device belongs to OptoTech Ltd, Nazareth, Israel. Dr. Assia is
the medical director of OptoTech Ltd.